Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1955 Mar;9(1):177–203. doi: 10.1038/bjc.1955.14

Further Studies on Incomplete Carcinogenesis: Triethylene Melamine (T.E.M.), 1,2-Benzanthracene and β-Propiolactone, as Initiators of Skin Tumour Formation in the Mouse

F J C Roe, M H Salaman
PMCID: PMC2073978  PMID: 14378502

Full text

PDF
182

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BADGER G. M. Chemical constitution and carcinogenic activity. Adv Cancer Res. 1954;2:73–127. doi: 10.1016/s0065-230x(08)60492-3. [DOI] [PubMed] [Google Scholar]
  2. BERENBLUM I. The effect of podophyllotoxin on the skin of the mouse, with reference to carcinogenic, cocarcinogenic, and anticarcinogenic action. J Natl Cancer Inst. 1951 Feb;11(4):839–841. [PubMed] [Google Scholar]
  3. BOYLAND E. Chemotherapy of cancer and leucaemias. Oncologia. 1954;7(2):144–154. doi: 10.1159/000223721. [DOI] [PubMed] [Google Scholar]
  4. Engstrom R. M., Kirschbaum A., Mixer H. W. Effect of Urethane on Mouse Myelogeno us Leukemia. Science. 1947 Mar 7;105(2723):255–256. doi: 10.1126/science.105.2723.255. [DOI] [PubMed] [Google Scholar]
  5. GALTON D. A. Myleran in chronic myeloid leukaemia; results of treatment. Lancet. 1953 Jan 31;264(6753):208–213. doi: 10.1016/s0140-6736(53)90885-x. [DOI] [PubMed] [Google Scholar]
  6. GELLHORN A. A critical evaluation of the current status of clinical cancer chemotherapy. Cancer Res. 1953 Mar;13(3):205–215. [PubMed] [Google Scholar]
  7. GRAFFI A. Uber den Mechanismus der Geschwulstbildung. Schweiz Med Wochenschr. 1953 Sep 12;83(37):865–872. [PubMed] [Google Scholar]
  8. GWYNN R. H., SALAMAN M. H. Studies on co-carcinogenesis. SH-reactors and other substances tested for co-carcinogenic action in mouse skin. Br J Cancer. 1953 Dec;7(4):482–489. doi: 10.1038/bjc.1953.50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. HENDRY J. A., HOMER R. F., ROSE F. L., WALPOLE A. L. Cytotoxic agents: III, derivatives of ethyleneimine. Br J Pharmacol Chemother. 1951 Sep;6(3):357–410. doi: 10.1111/j.1476-5381.1951.tb00650.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. HILL W. T., STANGER D. W., PIZZO A., RIEGEL B., SHUBIK P., WARTMAN W. B. Inhibition of 9,10-dimethyl-1,2-benzanthracene skin carcinogenesis in mice by polycyclic hydrocarbons. Cancer Res. 1951 Nov;11(11):892–897. [PubMed] [Google Scholar]
  11. Kennaway E. L. Further experiments on cancer-producing substances. Biochem J. 1930;24(2):497–504. doi: 10.1042/bj0240497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. King M. L., Sullivan M. M. The Similarity of the Effect of Podophyllin and Colchicine and Their Use in the Treatment of Condylomata Acuminata. Science. 1946 Sep 13;104(2698):244–245. doi: 10.1126/science.104.2698.244. [DOI] [PubMed] [Google Scholar]
  13. LASNITZKI I. Some effects of urethane on the growth and mitosis of normal and malignant cells in vitro. Br J Cancer. 1949 Dec;3(4):501-9, 4 pl. doi: 10.1038/bjc.1949.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. LOVELESS A., REVELL S. New evidence on the mode of action of mitotic poisons. Nature. 1949 Dec 3;164(4179):938–944. doi: 10.1038/164938a0. [DOI] [PubMed] [Google Scholar]
  15. Michaelis M., Quastel J. H. The site of action of narcotics in respiratory processes. Biochem J. 1941 Apr;35(4):518–533. doi: 10.1042/bj0350518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. NARPOZZI A. Sull'azione cancerigena dell'azoiprite; ricerche sperimentali. Riv Anat Patol Oncol. 1953 May;6(8):1155–1170. [PubMed] [Google Scholar]
  17. PETRAKIS N. L., BIERMAN H. R., KELLY K. H., WHITE L. P., SHIMKIN M. B. The effect of 1,4-dimethanesulfonyloxybutane (GT-41 or myleran) upon leukemia. Cancer. 1954 Mar;7(2):383–390. doi: 10.1002/1097-0142(195403)7:2<383::aid-cncr2820070225>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  18. Quastel J. H., Wheatley A. H. Narcotics and brain oxidations. Reversibility of narcotic action in vitro. Biochem J. 1934;28(4):1521–1529. doi: 10.1042/bj0281521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. ROE F. J., SALAMAN M. H. A quantitative study of the power and persistence of the tumour-initiating effect of ethyl carbamate (urethane) on mouse skin. Br J Cancer. 1954 Dec;8(4):666–676. doi: 10.1038/bjc.1954.72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. SALAMAN M. H., GWYNN R. H. The histology of co-carcinogenesis in mouse skin. Br J Cancer. 1951 Jun;5(2):252–263. doi: 10.1038/bjc.1951.26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. SMITH H. H., SRB A. M. Induction of mutations with beta-propiolactone. Science. 1951 Nov 9;114(2967):490–492. doi: 10.1126/science.114.2967.490. [DOI] [PubMed] [Google Scholar]
  22. Stedman E., Stedman E. Studies on the relationship between chemical constitution and physiological action: The inhibitory action of certain synthetic urethanes on the activity of esterases. Biochem J. 1932;26(4):1214–1222. doi: 10.1042/bj0261214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. WALPOLE A. L., ROBERTS D. C., ROSE F. L., HENDRY J. A., HOMER R. F. Cytotoxic agents. IV. The carcinogenic actions of some monofunctional ethyleneimine derivatives. Br J Pharmacol Chemother. 1954 Sep;9(3):306–323. doi: 10.1111/j.1476-5381.1954.tb01686.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. WILKINSON J. F., HADDOW A., NABARRO J. D. Discussion on the chemotherapy of the reticuloses. Proc R Soc Med. 1953 Sep;46(9):685–700. [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES